Bioxytran annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2022
2023
2024
2025
Bioxytran Revenue Growth & History (BIXT)
Bioxytran reported $0 in revenue for fiscal 2025.
View full Bioxytran company overviewBioxytran annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2017 | 2017-12-31 | $191,077 | −$55,418 | −22.48% |
| 2016 | 2016-12-31 | $246,495 | −$9,327 | −3.65% |
| 2015 | 2015-12-31 | $255,822 | −$19,794 | −7.18% |
| 2014 | 2014-12-31 | $275,616 | −$141,720 | −33.96% |
| 2013 | 2013-12-31 | $417,336 | $104,433 | +33.38% |
| 2012 | 2012-12-31 | $312,903 | $236,608 | +310.12% |
| 2011 | 2011-12-31 | $76,295 | $60,163 | +372.94% |
| 2010 | 2010-12-31 | $16,132 | — | — |
Bioxytran quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $20,310 | −$19,162 | −48.55% |
| Q1 2018 | 2018-03-31 | $13,316 | $5,880 | +79.07% |
| Q4 2017 | 2017-12-31 | $32,190 | −$26,010 | −44.69% |
| Q3 2017 | 2017-09-30 | $111,979 | $10,839 | +10.72% |
| Q2 2017 | 2017-06-30 | $39,472 | −$16,158 | −29.05% |
| Q1 2017 | 2017-03-31 | $7,436 | −$24,089 | −76.41% |
| Q4 2016 | 2016-12-31 | $58,200 | $35,048 | +151.38% |
| Q3 2016 | 2016-09-30 | $101,140 | −$9,640 | −8.70% |
| Q2 2016 | 2016-06-30 | $55,630 | −$3,770 | −6.35% |
| Q1 2016 | 2016-03-31 | $31,525 | −$30,965 | −49.55% |
| Q4 2015 | 2015-12-31 | $23,152 | $35,234 | +291.62% |
| Q3 2015 | 2015-09-30 | $110,780 | $69,282 | +166.95% |
| Q2 2015 | 2015-06-30 | $59,400 | $21,556 | +56.96% |
| Q1 2015 | 2015-03-31 | $62,490 | −$145,866 | −70.01% |
| Q4 2014 | 2014-12-31 | −$12,082 | −$160,530 | −108.14% |
| Q3 2014 | 2014-09-30 | $41,498 | −$14,195 | −25.49% |
| Q2 2014 | 2014-06-30 | $37,844 | −$61,053 | −61.73% |
| Q1 2014 | 2014-03-31 | $208,356 | $94,058 | +82.29% |
| Q4 2013 | 2013-12-31 | $148,448 | $84,693 | +132.84% |
| Q3 2013 | 2013-09-30 | $55,693 | $65,619 | +661.08% |
| Q2 2013 | 2013-06-30 | $98,897 | −$26,764 | −21.30% |
| Q1 2013 | 2013-03-31 | $114,298 | −$19,115 | −14.33% |
| Q4 2012 | 2012-12-31 | $63,755 | $40,677 | +176.26% |
| Q3 2012 | 2012-09-30 | −$9,926 | −$23,125 | −175.20% |
| Q2 2012 | 2012-06-30 | $125,661 | $93,574 | +291.63% |
| Q1 2012 | 2012-03-31 | $133,413 | $125,482 | +1582.17% |
| Q4 2011 | 2011-12-31 | $23,078 | — | — |
| Q3 2011 | 2011-09-30 | $13,199 | $11,409 | +637.37% |
| Q2 2011 | 2011-06-30 | $32,087 | $25,609 | +395.32% |
| Q1 2011 | 2011-03-31 | $7,931 | — | — |
| Q3 2010 | 2010-09-30 | $1,790 | — | — |
| Q2 2010 | 2010-06-30 | $6,478 | — | — |
Bioxytran revenue growth trends
Bioxytran's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Bioxytran source filings ↗